New Zealand dairy and infant-formula business Synlait Milk has agreed to sell its North Island assets to the local unit of US-based Abbott Laboratories. As Synlait announced today (29 September) it had returned to EBITDA profitability and trimmed net losses to NZ$40m (-$23.1m) in fiscal 2025, the company revealed the deal for the equivalent of US$178m with Abbott. The North Island assets, which were part of a strategic review last year, essentially consist of Synlait’s Pokeno factory, a blending and cann ...